πŸ“Œ Merative MarketScan Databases – Unites States πŸ‡ΊπŸ‡Έ

-

πŸ” What is it?

The Merative MarketScan Databases (formerly IBM MarketScan) are a set of comprehensive real-world data (RWD) sources derived from claims, encounters, and electronic health records (EHRs) across commercial, Medicare, and Medicaid populations in the United States. These databases support health economics and outcomes research (HEOR), pharmacoepidemiology, and regulatory decision-making.

-

πŸ“Š Key Features & Scope

πŸ“ Geographical coverage: United States πŸ‡ΊπŸ‡Έ

πŸ₯ Data type: De-identified health insurance claims, EHRs, and linked datasets covering inpatient, outpatient, and pharmacy claims

πŸ•’ Time coverage: Data available since the 1990s, with continuous updates

πŸ‘₯ Population covered: Over 270 million patients across commercial, Medicare, and Medicaid payers

πŸ”„ Longitudinal data: Tracks individuals over time, including healthcare utilization, diagnoses, procedures, and costs

πŸ“ˆ Therapeutic areas: Broad coverage across chronic conditions, oncology, infectious diseases, and rare diseases

-

βœ… Strengths & Best Use Cases

🌍 Comprehensive payer data – Covers commercially insured, Medicare, and Medicaid populations

πŸ’Š Pharmacoepidemiology & drug utilization – Ideal for analyzing medication adherence, persistence, and treatment patterns

πŸ“Š Cost & healthcare utilization insights – Enables economic burden assessments and healthcare resource use studies

πŸš€ Longitudinal tracking – Supports disease progression studies and healthcare pathways analysis

-

⚠️ Limitations & Considerations

πŸ₯ Lack of clinical detail – Primarily based on claims data, which may not capture disease severity, biomarkers, or patient-reported outcomes

πŸ“‰ Coverage gaps – Patients may switch insurers, leading to potential loss of follow-up in longitudinal studies

-

πŸ“š How to Access & Learn More

πŸ”— Access: Requires licensing through Merative

πŸŽ“ Publications: https://www.merative.com/insights

πŸ“„ More info: MarketScan by Merative